New target developed to improve production of important medical radioisotope
ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and producing less waste. ANSTO supplies the Australian medical community with molybdenum-99, the […]
